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Background: Plinia cerrocampanensis is an endemic plant of Panama. The leaf essential oil of this plant has shown
antibacterial activity. However, anti-malarial activity and chemical profiling by HS-SPME-GC-MS of this essential oil
have not been reported before.
Methods: Anti-malarial activity of the essential oil (EO) was evaluated in vitro against chloroquine-sensitive HB3 and
chloroquine-resistant W2 strains of Plasmodium falciparum. Synergistic effect of chloroquine and the EO on parasite
growth was evaluated by calculating the combination index. A methodology involving headspace solid phase
microextraction and gas chromatography-mass spectrometry (HS-SPME-GC-MS) was developed to investigate the
composition of Plinia cerrocampanensis EO.
Results: Plinia cerrocampanensis EO showed a high anti-malarial activity and a synergistic interaction with
chloroquine. The Plinia cerrocampanensis EO inhibited P. falciparum growth in vitro at an IC50 of 7.3 μg/mL.
Chloroquine together with the EO decreased the IC50 of chloroquine from 0.1 μg/mL to 0.05 μg/mL, and of the EO
from 7.3 μg/mL to 1.1 μg/mL. The measured combination index was 0.58, which clearly indicates that the EO acts
synergistically with chloroquine. Since the EO maintained its inhibitory activity on the chloroquine-sensitive strain of
the parasite, it could be acting by a different mechanism of action than chloroquine. The best HS-SPME-GC-MS
analytical conditions were obtained when the temperature of extraction was 49°C, incubation time 14 min, and the
time of extraction 10 min. This method allowed for the identification of 53 volatile constituents in the EO, including
new compounds not reported earlier.
Conclusions: The anti-malarial activity exhibited by the Plinia cerrocampanensis EO may lend support for its possible
use as an alternative for anti-malarial therapy.
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Malaria is a life-threatening tropical disease caused by
five species of Plasmodium, the most deadly of them in
humans being Plasmodium falciparum. According to the
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reproduction in any medium, provided the or219 million people around the world in 2010, causing
over 600,000 deaths. On the other hand, increased rate
of resistance to drugs used for treating patients has been
observed over the past 20 years [1]. Chloroquine resist-
ance has been reported in most of the malaria-endemic
regions, while resistance to artemisinin has been de-
tected in Cambodia, Thailand, Myanmar, and Vietnam
[1]. These facts highlight the challenge in discovery of
new drugs and new strategies for combating the disease.
Historically natural products, such as aromatic plants,
have been a source of new drugs and pharmacologicalLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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oils (EOs) are complex mixtures of terpenes and to a
lesser extent of non-terpenoid compounds. Extensive re-
search has been done on chemical characterization and
determination of the antibacterial, antifungal, antileish-
manial, and antiplasmodial activities of the EOs ex-
tracted from a wide variety of plants [2-7].
Plinia cerrocampanensis (Myrtaceae) is a tree that
grows to a height of c.8 m at an altitude of 800 and
1,000 m in the surroundings of Cerro Campana
National Park (Panama) [8]. The EO of this plant
has been reported to possess antimicrobial activity
against Staphylococcus aureus, Pseudomonas aerugi-
nosa, Microsporum gypseum, Trichophyton mentagro-
phytes, Trichophyton rubrum, and Helicobacter pylori
[9]. However, its anti-malarial activity has not been
reported before. Some terpenes have shown chemo-
therapeutic activity. For the extraction of the different
terpenoids, and other compounds that constitute an
EO, head-space solid phase microextraction (HS-
SPME) is a powerful tool that requires a minimal
amount of sample. The isolated compounds are sepa-
rated and identified by using GC-MS. SPME, which is
a simple, fast, sensitive, solvent-free method devel-
oped by Pawliszyn et al. [10,11] in the early 1990s,
and used for research in many fields, such as cancer
[12], medicinal plants [13] and metabolomic analysis
[14]. This methodology was used by Da Porto and
Decorti [15] for the determination of the aroma pro-
file of the EO obtained by hydro-distillation of laven-
der (Lavandula angustifolia) flowers.
The present study aimed to (a) evaluate in vitro anti-
malarial activity of Plinia cerrocampanensis EO against
P. falciparum; (b) study the possible synergistic inhibi-
tory effect of chloroquine and the EO on the growth of
the parasite; and (c) optimize a new HS-SPME-GC-MS
methodology for identification of the volatile constitu-
ents of Plinia cerrocampanensis EO, which could pos-
sibly explain the observed anti-malarial activity.
Methods
Plant material and extraction of the essential oil
Fresh leaves of Plinia cerrocampanensis were collected
in the Altos de Campana National Park (Province of
Panama, Panama). The plant was identified by Alex
Espinosa, taxonomist of CIFLORPAN, University of
Panama. Leaves were protected from humidity and
light until extraction of the EO. A voucher specimen
No. 6623 is deposited in the Herbarium of the Uni-
versity of Panama (PMA). Plinia cerrocampanensis
EO was extracted from 100 g of the collected plant
material by hydrodistillation, for three hours, using a
Clevenger-type apparatus as described in the European
Pharmacopeia [16].Cytotoxicity assay
Vero cells were seeded in 96-well plates using RPMI
1640 medium (Sigma-Aldrich, USA) supplemented with
10% foetal bovine serum (Gibco, Invitrogen, USA) and a
combination of 1% penicillin/streptomycin. The cells
were allowed to grow for 24 hours before adding the
EO, dissolved in dimethyl sulphoxide (DMSO), to final
concentrations of 10, 4, 0.2 and 0.08 μg/mL (w/v). A
negative control (with an equal volume of DMSO) was
placed in all plates and counted as 100% growth. All
samples were incubated for five days before staining and
examining for reduction of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) (Sigma Aldrich,
USA) and analysed four hours later in an ELISA plate
reader at a wavelength of 570 nm [17].
Anti-malarial activity
The W2 and the HB3 strains of P. falciparum were ob-
tained from the Malaria Research and Reference Reagent
Resource Centre (MR4, Manassas, VA, USA), and main-
tained in continuous culture for about two months before
new stocks were thawed. The parasites were grown and
maintained in cultures using the method of Haynes et al.
[18]. All chemicals except sodium bicarbonate and genta-
micin (Gibco; Invitrogen, USA), were purchased from
Sigma-Aldrich (USA). Cultures consisted of a 2% haemato-
crit suspension of O+ human erythrocytes in RPMI 1640
medium supplemented with a gentamicin solution at
0.01 mg/mL, 25 mM HEPES buffer, 25 mM NaHCO3, and
10% human serum. Cultures were fed with a gas mixture
consisting of 5% CO2, 5% O2, 90% N2 and incubated in a
cyclic incubator to achieve synchronization by tempera-
tures, as described by Almanza et al. [19]. Estimation of the
parasitaemia as well as visualization of parasite prior to the
assays were done using normal light (Giemsa stain) micro-
scopes. All samples were run in duplicate. The assay was
carried out in 96-well plates at final concentrations of 10, 2,
0.4 and 0.08 μg/mL and re-evaluated at higher or lower
concentrations as necessary. The final dilution contained
less than 1% DMSO, which had no measurable effect on
parasite survival. DMSO at a final concentration of 1% in
RPMI 1640 culture media was used as a negative control.
The positive control consisted of chloroquine (CQ) at con-
centrations of 1,000, 200, 100, 50, and 10 nM. The para-
sites were incubated for 48 hours at which point 50 μL of
a PicoGreen cocktail (Invitrogen, USA) were added to each
well and the fluorescence determined after 30 min at
485 nm in a fluorometer. To measure the effect of the sam-
ples alone on the fluorescence signal, each extract concen-
tration was incubated in the absence of parasites and the
signal was subtracted from the value obtained in the pres-
ence of samples and parasites. For the synergistic studies,
different doses of CQ (10, 50, 100, 200 and 1,000 nM) and
Plinia cerrocampanensis EO (0.08, 0.4, 2 and10 μg/ml) were
Table 1 MS detector peak area of some volatile
metabolites in Plinia cerrocampanensis essential oil
analysed by using three different SPME fibres
Mean MS response value (×107)
Compound DVB/CAR/PDMS CAR/PDMS DVB/PDMS
1 Furfural 67.2 - -
2 α-Pinene 584.0 632.0 894.0
3 Benzaldehyde 257.0 - 201.0
4 γ-Terpinene 1150.0 799.5 -
5 Terpinolene 547.0 - -
6 Linalool 2390.0 - 2630.0
7 Neo-allo-ocimene 106.0 239.7 30.8
8 4-Terpineol 599.0 467.0 660.0
9 α-Terpineol 231.0 194.0 261.0
10 Nerol 12.9 8.8 15.5
11 Geraniol 26.8 14.3 30.8
12 α-Copaene 663.0 639.0 741.0
13 Sativene 11.1 - -
14 α-Cedrene 140.0 - 229.0
15 Caryophyllene 114.0 112.0 132.0
16 α-Bergamotene 112.0 105.1 129.0
17 Epi-β-santalene 33.0 - -
18 α-Humelene 46.1 46.7 55.5
19 β-Acoradiene 69.2 81.3 93.2
20 γ -Muurolene 89.6 87.2 103.0
21 α-Muurolene 80.3 53.5 96.4
22 α-Curcumene 191.0 170.9 184.0
23 β -Bisabolene 907.0 480.3 1100.0
24 δ-Cadinene 291.0 277.0 328.0
25 trans-Nerolidol 195.0 83.8 243.0
26 Cubenol 11.8 8.4 -
27 Bisabolol oxide II 37.9 - 47.7
28 α-Bisabolol 159.0 58.0 213.0
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varying the other.
Statistical analysis was carried out with the LSW
DATb add-on of Microsoft Office Excel. The significance
level was p <0.05.
Solid phase microextraction fibre selection
Three fibres were evaluated in this research: car-
boxen-polydimethylsiloxane StableFlex (CAR/PDMS,
75 μm), polydimethylsiloxane-divinylbenzene Stable-
Flex (PDMS/DVB, 65 μm), and divinylbenzene-
carboxen-polydimethylsiloxane StableFlex (DVB/CAR/
PDMS 50/30 μm) (Supelco, Bellefonte, PA, USA). All
fibres were conditioned in the gas chromatograph in-
jector port at the temperature and time recommended
by the manufacturer.
Five hundred milligrams of Plinia cerrocampanensis EO
(liquid matrix) were transferred to a 10 mL vial and her-
metically sealed. The sample was equilibrated during
20 min at 30°C in a thermostatic bath. Then the fibre was
exposed to sample headspace for 15 min. After the sam-
pling period, the SPME fibre was inserted into the GC
injector port and maintained there for 7 min at 250°C for
desorption of compounds.
Experimental design
The times of incubation and extraction and temperature
of extraction are critical parameters that determine the
equilibrium, vapour pressures and extraction efficiency
of volatiles in the headspace [20]. These variables, which
strongly influence the efficiency of the HS-SPME-GC-
MS, were optimized by using a Doehlert design. Sixteen
randomized experiments were performed in duplicate.
The total GC-MS peak areas were used as response.
Statistical analysis was done using Statgraphics Plus 5.1
(Statistical Graphics, Rockville, MD, USA).
Gas chromatography-mass spectrometry analysis
All the analyses were performed on an Agilent 6890 N gas
chromatograph (GC) equipped with a 5975C mass-
selective detector (MSD) with triple-axis detector (Agilent
Technologies, Palo Alto, CA, USA). The separation was
achieved on a DB5-MS capillary column (30 m length,
0.25 mm id, 0.25 μm film thickness), Agilent Technologies,
Palo Alto, CA, USA).
Gas chromatograph oven initial temperature was kept at
50°C for 2 min, then increased to 240°C at 6°C min-1 and
held for 5 min. The injector temperature was maintained at
250°C, using splitless injection mode (2 min). Helium was
used as carrier gas with a constant flow-rate of 1 mL min-1.
The mass spectrometer was operated in scan mode from
30-550 m/z; ion source temperature was set at 250°C; the
ionization was performed in the impact ionization mode
(EI) with the ionization voltage set to 70 eV.Identification of the compounds was carried out based
on comparison of their fragmentation patterns using au-
thentic standards when available and the NIST 11 Mass
Spectral Search Program (NIST, Washington, USA), and
with data from the literature [21]. Further identification of
the compounds was achieved by comparison of their calcu-
lated experimental linear Kovat’s retention indices (KI) with
those reported in the literature using chromatographic col-
umns of similar stationary phase composition.
Results
Headspace solid phase microextraction fibre selection
The first HS-SPME parameter optimized for char-
acterization of the metabolites of Plinia cerrocampanensis
EO was the selection of the SPME fibre. In this study three
Table 2 Experimental Doehlert design matrix used for optimization of extraction parameters of Plinia
cerrocampanensis essential oil by HS-SPME
Experiment Extraction temperature (°C) Time of equilibrium (min) Time of extraction (min) Total peak area (109)
1 45 25 20 136.86
2 60 25 20 1.41
3 52 25 35 6.84
4 52 40 25 9.47
5 30 25 20 50.99
6 38 25 5 43.98
7 38 10 15 111.39
8 52 25 5 139.92
9 52 10 15 137.97
10 38 25 35 106.08
11 45 10 30 100.77
12 38 40 25 100.85
13 45 40 10 122.17
14 45 40 10 121.96
15 45 40 10 122.20
16 45 40 10 120.34
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ferent coating polymers, were compared for assessing their
concentration capacity. SPME fibres with more than one
coating have shown to be the most effective when studying
medicinal and aromatic plants [22].
The extraction efficiency of each fibre was determined on
the basis of two main criteria, the total MS-detector peak
area and the number of identified compounds. The DVB/
CAR/PDMS fiber permitted the identification of a larger
number of constituents of the EO than CAR/PDMS and
DVB/PDMS fibers. Furthermore, DVB/CAR/PDMS total
peak response (9.12 × 1010) was higher than that obtained
with DVB/PDMS (8.42 × 1010) and CAR/PDMS (4.55 ×
1010) fibres (Table 1). DVB/CAR/PDMS is an adsorption-Figure 1 Pareto chart of standardized effects of extraction temperatubased fibre made of polydimethylsiloxane (PDMS) coating
that allows the absorption of less polar substances; car-
boxen (CAR) and divinylbenzene (DVB) porous coating
materials that provide high selectivity and sensitivity for
more polar compounds. This fibre was selected as the most
appropriate for obtaining the widest composition profile of
Plinia cerrocampanensis EO, and was used in all further
experiments.
Optimization of the HS-SPME extraction procedure
The times of extraction and incubation and temperature
of extraction are important factors that determine the ef-
ficiency of the overall HS-SPME extraction process [23].
Thus, these parameters were optimized by using a three-re, time of incubation and time of extraction.
AB
C
Figure 2 Fitted response surface plot. (A) Extraction temperature
(°C) vs time of extraction (min). (B) Extraction temperature (°C) vs
time of incubation (min). (C) Time of incubation (min) vs time of
extraction (min).
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lows for the simultaneous evaluation of the factors under
study. Table 2 shows the experimental Doehlert design
matrix and the response in terms of total area of the
compounds identified from Plinia cerrocampanensis EO
(liquid matrix). The design consisted of 16 randomized
experiments to avoid systematic errors. Analysis of vari-
ance (ANOVA) was performed for determining the stat-
istical significance (p <0.05).
Figure 1 shows the Pareto chart of the standardized ef-
fects. As can be observed, all three of the evaluated factors
were significant, and increasing their value affected nega-
tively the extraction. Among the HS-SPME parameters
studied the time of extraction had the greatest influence on
the extraction efficiency, while the temperature of extraction
was less significant.
HS-SPME is an equilibrium process among three phases,
the sample matrix, a gaseous headspace and the fibre coat-
ing. A first equilibrium is established between the analytes
in the matrix and the headspace; subsequently, the SPME
fibre is introduced in the headspace leading to a new equi-
librium between the analytes in the headspace and in the
fibre [24]. By raising the temperature the amount of analytes
released from Plinia cerrocampanensis EO and extracted by
the SPME fibre increased until an optimal value at 49°C
(Figure 2A), after which higher temperatures influenced
negatively the results. As the extraction temperature in-
creases the Henry’s constant of the analytes also increases,
as well as the amount of compounds released from the li-
quid phase, especially less volatile compounds. Both physi-
cochemical phenomena improve the extraction efficiency.
Nevertheless, above 49°C the amount of compounds ex-
tracted by the SPMEDVB/CAR/PDMS fibre tends to decrease
due to desorption of compounds from the fibre.
Incubation time influences the number of compounds
that are transferred from the liquid matrix and reach the
headspace. The effect of this variable on analytical response
is shown in Figure 2. A maximum response was observed at
14 min. No improvement on extraction of EO metabolites
was observed by increasing the incubation time.
In order to assess the effect of extraction time on the
analysis, the SPMEDVB/CAR/PDMS fibre was introduced
into the sample headspace for different periods. The op-
timal response was achieved with an extraction time of
10 min (Figure 2). HS-SPME is an equilibrium process
influenced strongly by the partition coefficient of the
compounds between the liquid phase and the headspace
(Kfiber/matrix).
Withdrawing the SPME fibre from the headspace be-
fore 10 min did not allow this equilibrium to be
achieved, and hence less metabolites were extracted.
Conversely, higher time of extraction reduced the total
volatile recovery due to diffusion of the analytes from
the fibre [25].According to the experimental results, the best analytical
response was obtained when the temperature of extraction
was 49°C, incubation time 14 min, and time of extraction
10 min. These optimal values were selected for extraction of
the EO metabolites in all further experiments.
Chemical composition of the essential oil of Plinia
cerrocampanensis by HS-SPME-GC-MS
This is the first time that the chemical composition pro-
filing of Plinia cerrocampanensis EO has been studied by
Table 3 Chemical composition of Plinia cerrocampanensis B. essential oil by HS-SPME-GC-MS
Peak no Compound KIa m/z Percentage composition (%)
1 Furfural 830 95-67–42 0.21
2 α-Pinene 933 93–79–41 1.96
3 Benzaldehyde 958 105–77–51 1.10
4 Myrcene 982 41–93–69 0.91
5 3-δ-Carene 1006 93–79–41 0.90
6 o-Cymene 1020 119–91–134 6.85
7 trans-β-Ocimene 1041 93–79–41 2.62
8 cis-β-Ocimene 1053 93–91–79 2.58
9 γ-Terpinene 1067 93–77–41 4.70
10 Terpinolene 1092 93–121–136 2.01
11 Linalool 1104 43–71–55 10.47
12 Fenchol 1121 81–43–67 0.06
13 cis-Sabinol 1133 92–81–109 0.11
14 Neo-allo-ocimene 1140 121–105–79 2.72
15 1,4-Dimethyl-4-acetyl-1-cyclohexene 1157 109–67–43 0.04
16 Trans,cis-2,6-Nonadienal 1163 41–70–39 0.05
17 Terpin-4-en-1-ol 1174 43–71–93 2.22
18 m-Methylacetophenone 1188 119–91–65 0.15
19 α-Terpinol 1196 59–43–93 1.20
20 β-Cyclocitral 1214 41–137–123 0.06
21 Nerol 1229 41–69–81 0.12
22 p-Menth-1(7)-en-2-one 1241 82–81–152 0.07
23 Carvenone 1248 95–110–67 0.18
24 Geraniol 1255 41–69–81 0.29
25 cis-2-Decenal 1272 41–55–70 0.04
26 Carvacrol 1313 135–91–150 0.05
27 α-Copaene 1365 105–119–161 8.86
28 Sativene 1390 108–41–91 0.19
29 Ylangene 1400 105–119–93 0.89
30 α-Cedrene 1412 119–41–105 0.92
31 trans-β-Caryophyllene 1420 41–91–79 1.34
32 α-Bergamotene 1440 41–93–119 1.93
33 γ-Elemene 1449 121–41–93 1.24
34 Epi-β-santalene 1453 94–41–79 0.52
35 α-Humelene 1458 93–41–67 0.54
36 β-Farnesene 1462 41–69–91 1.97
37 β-Acoradiene 1469 119–41–105 1.05
38 γ-Gurjunene 1476 105–91–81 0.82
39 γ -Muurolene 1484 161–41–105 1.42
40 α-Curcumene 1490 119–132–41 3.83
41 Indipone 1499 149–93–41 1.18
42 α-Muurolene 1507 105–41–161 0.95
43 β-Bisabolene 1513 41–69–93 16.26
44 δ-Cadinene 1527 119–161–41 4.21
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Table 3 Chemical composition of Plinia cerrocampanensis B. essential oil by HS-SPME-GC-MS (Continued)
45 γ-Bisabolene 1540 41–93–107 2.19
46 trans- Nerolidol 1558 41–69–93 2.68
47 Spathulenol 1569 43–91–79 0.27
48 tau-Cadinol 1632 43–161–81 0.26
49 Cubenol 1649 43–161–95 0.26
50 Bisabolol oxide B 1666 43–59–105 0.92
51 β-Bisabolol 1674 41–67–93 0.15
52 α-Bisabolol 1687 43–119–109 3.46
53 α-Farnesol 1709 41–69–81 0.01
aRetention index. Components are listed in increasing order of their retention indices on DB5-MS.
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stituents identified in the EO analysed. Fifty-three
compounds were identified by this methodology. The
main constituents (more than 2% of the identified
compounds) were β-bisabolene, β-linalool, α-copaene,
o-cymene, γ- terpinene, δ-cadinene, α-curcumene, α-
bisabolol, neo-allo-ocimene, trans-nerolidol, trans-β-oci-
mene, β-ocimene, γ-bisabolene and terpinolene (Table 3).
Vila et al. have reported the chemical composition of
the EO obtained from leaves of Plinia cerrocampanensis
utilizing two different GC-columns, i e, a non-polar and
a polar phase columns, identifying 40 compounds: 33
compounds were identified on the non-polar phase col-
umn, and 31 on the polar phase column [9]. Clearly, the
more sensitive HS-SPME-GC-MS methodology devel-
oped in this study allowed the identification of a higher
number of compounds in a single chromatographic run.
The current investigation reports for the first time
new compounds present in the EO obtained from
leaves of Plinia cerrocampanensis, such as neo-allo-
ocimene, γ-elemene, caryophyllene, acoradiene, γ-
muurolene, and β-myrcene.
Sesquiterpene hydrocarbons (49.13%), and monoter-
pene hydrocarbons (25.25%) were the most abundant
chemical class of compounds identified by HS-SPME-
GC-MS, followed by oxygenated monoterpenes (15.03%),
oxygenated sesquiterpenes (9.19%) and aldehydes (1.35%).Anti-malarial activity
This is the first report on the anti-malarial activity of the
EO from Plinia cerrocampanensis. The antiplasmodial
effects of Plinia cerrocampanensis EO were determined
by quantifying the growth inhibition of the CQ-resistant
P. falciparum W2 strain when compared with parasites
cultured in a medium free of the EO. The Plinia cerro-
campanensis EO inhibited parasite growth in vitro at
IC50 7.3 μg/mL. This value indicates a high antiplasmo-
dial activity. The activity of the oil was lower than that
of chloroquine (IC50 = 0.1 μg/mL), which could resultfrom several factors, one of them being the dilution of
the active compound (s) in the matrix.
To get an idea of the mechanism by which the EO was
acting on P. falciparum, its activity against a CQ-sensitive
strain, HB3, was tested and compared the results with those
obtained with the CQ-resistant W2. While CQ shows dif-
ference in IC50 in the resistant (IC50 = 0.1 μg/mL) and sen-
sitive (IC50 = 0.01 μg/mL) strains, the EO maintained its
level of activity, in both the resistant (IC50 = 7.3 μg/mL) and
sensitive (IC50 = 10.2 μg/mL) strains. These results suggest
that the EO may be using another mechanism that does
not involve inhibition of β-haematin formation nor inhib-
ition of the peroxidative degradation of haemin, since CQ
and other quinolones with anti-malarial activity are thought
to act through these two mechanisms [26,27].
The EO caused toxicity to mammalian cells at a con-
centration of 28.6 μg/mL, which is four-fold higher than
the concentration at which the oil showed antiplasmo-
dial effects, projecting a reasonable therapeutic window
for its use in vivo. The HS-SPME-GC-MS methodology
developed in this study allowed the identification of ter-
penes and terpenoids in the EO of Plinia cerrocampa-
nensis: α-pinene, β-linalool, trans-nerolidol, α-bisabolol
and α-farnesol, which have been reported to possess
antiplasmodial activity and, therefore, may explain the
observed anti-malarial activity of EO [28-30].
The monoterpene α-pinene displayed a stronger anti-
malarial activity than quinine when tested against a CQ-
resistant strain of P. falciparum, mainly affecting the
ring stage of the parasite [29]. β-linalool and farnesol ar-
rest the growth of the apicomplexan mainly by (a) affect-
ing the dolichol biosynthesis at the trophozoite and
schizont stages; and, (b) inhibiting the biosynthesis of
the isoprene side chain of the benzoquinone ring of ubi-
quinones [30]. Treatment of P. falciparum with the iso-
lated oxygenated sesquiterpene α-bisabolol caused
inhibition in the development of parasites [30]. Macedo
et al. demonstrated the high activity of the sesquiterpene
trans-nerolidol against P. falciparum by decreasing its
ability to biosynthesize the isoprene chain attached to
Figure 3 Isobologram and combination index (CI) of
chloroquine (CQ) and the essential oil (EO) of Plinia
cerrocampanensis. The 50% contour line shows a less than 1
combination index which shows synergy between EO and CQ at
concentration (EO, CQ).
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ity displayed by the Plinia cerrocampanensis EO was
higher than the activity observed for these compounds,
suggesting that trace components of the oil could be en-
hancing the effect of the active components. A possible
synergism among the different constituents of the oil
could also be responsible for its anti-malarial activity.
To determine possible synergistic or additive effects
when applied with other drugs, the activity of the EO
was examined in conjunction with CQ at different con-
centrations. Synergism or additive effect was evaluated
by calculating the combination index (CI) as described
by Chou and Talahay [32] using the following formula:








where D is the concentration at which both compounds
show the same desired efficacy (ED) in combination, and
Dx is the concentration at which each of the compounds
alone show this ED [32]. A synergistic effect is achieved
if CI is <1.0 while an additive effect is obtained at
CI = 1.0. The application of CQ together with the EO on
strains of P. falciparum, decreased the IC50 for CQ from
0.1 μg/mL to 0.05 μg/mL, and for the EO from 7.3 μg/mL
to 1.1 μg/mL (Figure 3).
This means that a higher in vitro activity against the
parasite was obtained for the oil and CQ when applied
together. The measured CI combination was 0.58, which
clearly indicates that the EO acted synergistically with
CQ. Moreover, the therapeutic window of the EO in-
creased substantially in the presence of a very small
amount of CQ. Based on the physico-chemical proper-
ties of the EO, it could also cause the disruption of the
parasite cell membrane, which affects the permeability
of the cell and the transfer of important biochemicalsubstances needed by the parasite for sustaining crucial
metabolic processes. The reduction in the concentration
of CQ required for achieving its therapeutical effect may
not only lower the incidence of adverse reactions in
humans, but most importantly, may promote the use of
this cost effective drug in the large regions worldwide
where resistance to it has been observed.
Conclusions
This research demonstrated that the EO of Plinia
cerrocampanensis could be a potential alternative for the
treatment of malaria. Moreover, due to the synergistic
anti-malarial activity of the EO and the CQ, this could be
used in combination with CQ as anti-malarial therapy.
The studies are underway to determine the anti-malarial
effect of major isolated compounds in the EO of Plinia
cerrocampanensis.
The developed HS-SPME-GC-MS methodology allowed
for the identification of new constituents in the EO of
Plinia cerrocampanensis. Monoterpenes and sesquiter-
penes, which constitute most of the volatile organic com-
pounds of the essential oil, could be responsible for the
bioactivity showed by the oil in this study.
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